Efficacy of intra-articular polynucleotides in the treatment of knee osteoarthritis: A randomized, double-blind clinical trial

Knee Surgery, Sports Traumatology, Arthroscopy

Volumn 18, Issue 7, 2010, Pages 901-907

  Vanelli, Roberto ^a   Costa, Pietro ^a   Rossi, Stefano Marco Paolo ^a   Benazzo, Francesco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Condrotide; Hyaluronic acid; Intra articular; Osteoarthritis; Polynucleotides; Turnover Joint

Indexed keywords

HYALURONIC ACID; POLYNUCLEOTIDE; VISCOSUPPLEMENT;

ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; JOINT CHARACTERISTICS AND FUNCTIONS; KNEE OSTEOARTHRITIS; MALE; MIDDLE AGED; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARTHRALGIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; POLYNUCLEOTIDES; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; VISCOSUPPLEMENTS;

EID: 77953915338     PISSN: 09422056     EISSN: 14337347     Source Type: Journal    
DOI: 10.1007/s00167-009-1039-y     Document Type: Article

References (23)

1. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29: 1039-1049.
2. Altman RD, Aven A, Holmburg CE et al (1994) Capsaicin cream 0. 025% as monotherapy for osteoarthritis: a double-blind study. Semin Arthritis Rheum 23: 25-33.
3. Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Müllner M (2005) Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. Can Med Assoc J 172: 1039-1043.
4. Bellamy N, Campbell J, Robinson V et al (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2: CD005321.
5. De Aloe G, Rubegni P, Biagioli M, Taddeucci P, Fimiani M (2004) Skin graft donor site and use of PDRN as a treatment for skin regeneration: a randomized, controlled, double-blind, clinical trial. Wounds 16: 258-263.
6. Guizzardi S, Galli C, Govoni P, Boratto P, Cattarini G, Martini D, Belletti S, Scandroglio R (2003) Polydeoxyribonucleotide (PDRN) promotes human osteoblast proliferation: a new proposal for bone tissue repair. Life Sci 73: 1973-1983.
7. Karlsson J, Sjögren LS, Lohmander LS (2002) Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 41: 1240-1248.
8. Knutsen G et al (2007) A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 89: 2105-2112.
9. Lo GH, LaValley M, McAlindon T, Felson DT (2003) Intra-articular hyaluronic acid in treatment of knee osteoarthritis-a meta-analysis. JAMA 23: 3115-3121.
10. Muratore O, Cattarini G, Gianoglio S, Tonoli EL, Saccà SC, Ghiglione D, Venzano D, Ciurlo C, Lantieri PB, Schito GC (2003) A human placental polydeoxyribonucleotide (PDRN) may promote the growth of human corneal fibroblasts and iris pigment epithelial cells in primary cultures. New Microbiol 26: 13-26.
11. Muratore O, Pesce Schito A, Cattarini G, Tonoli EL, Gianoglio S, Schiappacasse S, Felli L, Picchetta F, Schito GC (1997) Evaluation of the trophic effect of human placental PDRN on human knee skin fibroblasts in primary cultures. Cell Mol Life Sci 53: 279-285.
12. Murray CJ, Lopez AD (1996) Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 274: 740-743.
13. Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A (2009) Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 8: 110-123.
14. Reichenbach S, Sterchi R, Scherer M et al (2007) Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 146: 580-590.
15. Roos EM, Lohmander LS (2003) The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to Osteoarthritis. Health Qual Life Outcomes 1: 64.
16. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD (1998) Knee Injury and Osteoarthritis Outcome Score (KOOS)-development of a self-administered outcome measure. J Orthop Sports Phys Ther 28: 88-96.
17. Roos E, Toksvig-Larsen S (2003) Knee injury and Osteoarthritis Outcome Score (KOOS)-validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes 1: 17.
18. Sini P, Denti A, Cattarini G, Daglio M, Tira ME, Balduini C (1999) Effect of polydeoxyribonucleotides on human fibroblasts in primary cultures. Cell Biochem Funct 17: 107-114.
19. Thellung S, Florio T, Maragliano A, Cattarini G, Schettini G (1999) Polydeoxyribonucleotides enhance the proliferation of human skin fibroblasts: involvment of A2 purinergic receptors subtypes. Life Sci 64: 1661-1674.
20. Valdatta L, Thione A, Mortarino C, Buoro M, Tuinder S (2004) Evaluation of the efficacy of polydeoxyribonucleotide in the healing process of autologous skin graft donor sites: a pilot study. Curr Med Res Opin 20: 403-408.
21. van Assche D, Staes F, van Caspel D, Vanlauwe J, Bellemans J, Saris DB, Luyten FP (2009) Autologous chondrocyte implantation versus microfracture for knee cartilage injury: a prospective randomized trial, with 2-year follow-up. Knee Surg Sports Traumatol Arthrosc.
22. Woessner JF, Howell DS (1993) Joint cartilage degradation: basic and clinical aspects. Marcel Dekker, New York.
23. Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81: 646-656.